4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-050166
Chief Executive Officer sold 4,400 shares at an average $13.54 ($59,554)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2017-08-22 | Sale | −2,200 | $13.56 | $29,832 | 443,978 | I: show line 1 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2017-08-23 | Sale | −2,200 | $13.51 | $29,722 | 441,778 | I: show line 2 in the form |
| Open-market sales · 4,400 sh · avg $13.54 · $59,554 | |||||||
Loading xslF345X03/doc4.xml…